{
    "2020-08-19": [
        [
            {
                "time": "2018-01-03",
                "original_text": "Strong, Diverse Dividend Stocks to Buy with Market at New Highs",
                "features": {
                    "keywords": [
                        "strong",
                        "dividend",
                        "stocks",
                        "market",
                        "new highs"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-04",
                "original_text": "FDA Denies Approval for Gilead Sciences' Potential Blockbuster Arthritis Drug",
                "features": {
                    "keywords": [
                        "FDA",
                        "denies",
                        "approval",
                        "Gilead",
                        "blockbuster",
                        "arthritis",
                        "drug"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-05",
                "original_text": "Potential Gilead Blockbusters Were Rejected By the FDA. Why That’s the ‘Near-Worst-Case Scenario’ for the Stock.",
                "features": {
                    "keywords": [
                        "potential",
                        "Gilead",
                        "blockbusters",
                        "rejected",
                        "FDA",
                        "near-worst-case",
                        "scenario",
                        "stock"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-06",
                "original_text": "Dow Jones Today, Stocks Mixed; Target Heads Retail Rally; Biotechs Momenta, Gilead, BioMarin Swing Wild On Merger, FDA News",
                "features": {
                    "keywords": [
                        "Dow",
                        "Jones",
                        "stocks",
                        "mixed",
                        "Target",
                        "retail",
                        "rally",
                        "biotechs",
                        "Momenta",
                        "Gilead",
                        "BioMarin",
                        "swing",
                        "wild",
                        "merger",
                        "FDA",
                        "news"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "retail"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "mixed"
                }
            },
            {
                "time": "2018-01-07",
                "original_text": "Dow Jones Today, Stocks Open On This Rise; Target Heads Retail Rally; Biotechs Momenta, Gilead, Biomarin Swing Wild On Merger, FDA News",
                "features": {
                    "keywords": [
                        "Dow",
                        "Jones",
                        "stocks",
                        "open",
                        "rise",
                        "Target",
                        "retail",
                        "rally",
                        "biotechs",
                        "Momenta",
                        "Gilead",
                        "Biomarin",
                        "swing",
                        "wild",
                        "merger",
                        "FDA",
                        "news"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "retail"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-08",
                "original_text": "Dow Jones Today, Futures Mixed; Target Heads Retail Rally; Gilead, Biomarin Swoon As FDA Balks",
                "features": {
                    "keywords": [
                        "Dow",
                        "Jones",
                        "futures",
                        "mixed",
                        "Target",
                        "retail",
                        "rally",
                        "Gilead",
                        "Biomarin",
                        "swoon",
                        "FDA",
                        "balks"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "retail"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}